Technical Analysis for GLUE - Monte Rosa Therapeutics, Inc.

Grade Last Price % Change Price Change
B 30.66 11.01% 3.04
GLUE closed up 11.01 percent on Wednesday, August 4, 2021, on 81 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up
Historical GLUE trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Older End-of-Day Signals for GLUE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 17 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Up 1 ATR about 19 hours ago
Up 5% about 19 hours ago
Rose Above Previous Day's High about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Monte Rosa Therapeutics, Inc. Description

Monte Rosa Therapeutics is a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins. The company has developed a proprietary protein degradation platform, called QuEEN™, that enables it to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates that are designed to eliminate therapeutically relevant proteins in a highly selective manner. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine and is headquartered in Boston, Mass., with research operations in both Boston and Basel, Switzerland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Drug Discovery Machine Learning Proteomics

Is GLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 31.425
52 Week Low 18.01
Average Volume 264,872
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 22.15
10-Day Moving Average 24.57
Average True Range 2.07
ADX 30.1
+DI 37.90
-DI 6.22
Chandelier Exit (Long, 3 ATRs) 25.21
Chandelier Exit (Short, 3 ATRs) 24.23
Upper Bollinger Bands 28.37
Lower Bollinger Band 15.92
Percent B (%b) 1.18
BandWidth 56.23
MACD Line 2.11
MACD Signal Line 1.22
MACD Histogram 0.8918
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.62
Resistance 3 (R3) 36.22 33.82 35.63
Resistance 2 (R2) 33.82 32.30 34.02 35.30
Resistance 1 (R1) 32.24 31.36 33.03 32.65 34.97
Pivot Point 29.85 29.85 30.24 30.05 29.85
Support 1 (S1) 28.27 28.33 29.06 28.67 26.35
Support 2 (S2) 25.87 27.39 26.07 26.02
Support 3 (S3) 24.29 25.87 25.69
Support 4 (S4) 24.70